Form D · Other Health Care

ADMA BIOLOGICS, INC.

Hackensack, NJ · CIK 0001368514

Offering snapshot reported Jan 7, 2013 · SEC filing

Reported sold
$0
Offering amount: $0
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 21, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 7, 2013Initial$0No comparison1SEC filing
Feb 28, 2012Initial$0No comparison9SEC filing

Offering details

Securities
Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-189666
Warrant to purchase 25,000 shares issued to lender as partial consideration under loan agreement. No separate cash consideration received.

Source: Form D, filed Jan 7, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven A. Elms Director
Bryant E. Fong Director
Dov A. Goldstein Director
Jerrold B. Grossman Director
Adam S Grossman Director, Executive
Lawrence P. Guiheen Director
Brian Lenz Executive
James Mond Executive
Eric I. Richman Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
65 Commerce Way
Hackensack, NJ, 07601